Sarcopenia Treatment Market Poised for Growth, Expected to Reach $4.44 Billion by 2028

The Business Research Company's Sarcopenia Treatment Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033

LONDON, GREATER LONDON, UK, June 20, 2024 /EINPresswire.com/ -- The sarcopenia treatment market has seen robust growth in recent years, with projections indicating continued expansion. From $3.30 billion in 2023, the market is expected to reach $3.52 billion in 2024, growing at a compound annual growth rate (CAGR) of 6.6%. It will grow to $4.44 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. This growth can be attributed to factors such as the aging population, increased awareness and diagnosis, lifestyle changes, public health initiatives, and regulatory approvals.

Rise in Malnutrition Propels Market Growth
The rise in malnutrition globally is a significant driver for the sarcopenia treatment market. Malnutrition exacerbates age-related muscle loss, making interventions crucial for improving muscle mass, strength, and overall nutritional status. According to a December 2023 report by the World Health Organization (WHO), malnutrition remains a pressing global health challenge, underscoring the urgent need for effective treatment solutions.

Explore the global sarcopenia treatment market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=13926&type=smp

Major Players and Market Trends
Leading companies such as Pfizer Inc., F-Hoffmann La-Roche, and Merck Sharp & Dohme Corp. are actively engaged in advancing clinical options and developing innovative treatments. For example, Biophytis recently received FDA authorization to initiate the SARA-31 Phase 3 study, evaluating Sarconeos (BIO101) for sarcopenia treatment. This study marks a significant milestone in the field, focusing on efficacy and safety improvements for severe sarcopenic patients.

Segments
• Treatment Type: Protein Supplements, Vitamin B12 Supplements, Vitamin D and Calcium Supplements, Other Treatment Types
• Type: Primary Sarcopenia, Secondary Sarcopenia
• Route of Administration: Oral, Parenteral, Enteral
• Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

Geographical Insights: Asia-Pacific Leading Growth
North America dominated the sarcopenia treatment market in 2023, while Asia-Pacific is expected to emerge as the fastest-growing region in the coming years. Detailed regional dynamics and growth opportunities are covered extensively in the comprehensive market report.

Access the complete report for an in-depth analysis of the global sarcopenia treatment market: https://www.thebusinessresearchcompany.com/report/sarcopenia-treatment-global-market-report

Sarcopenia Treatment Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Trends, opportunities, strategies and so much more.
The Sarcopenia Treatment Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on sarcopenia treatment market size, sarcopenia treatment market drivers and trends, sarcopenia treatment market major players, competitors' revenues, market positioning, and market growth across geographies. The sarcopenia treatment market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.

Browse Through More Similar Reports By The Business Research Company:
Intestinal Pseudo Obstruction Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/intestinal-pseudo-obstruction-treatment-global-market-report

Reversible Airway Diseases Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/reversible-airway-diseases-treatment-global-market-report

Urothelial Carcinoma Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/urothelial-carcinoma-treatment-global-market-report

About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.

Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn